Ragweed allergy vaccine sublingual - Greer Laboratories

Drug Profile

Ragweed allergy vaccine sublingual - Greer Laboratories

Alternative Names: SAIL™ standardized short ragweed extract; Short ragweed extract immunotherapy - Greer Laboratories; Sublingual Allergy Immunotherapy Liquid

Latest Information Update: 11 Sep 2015

Price : $50

At a glance

  • Originator Greer Laboratories
  • Class Allergens; Antiallergics; Plant allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Seasonal allergic rhinitis

Most Recent Events

  • 14 May 2015 No recent reports on development identified - Phase-III for Seasonal allergic rhinitis in USA (Sublingual)
  • 10 Mar 2014 Development of the sublingual ragweed allergy vaccine is ongoing
  • 25 Feb 2013 Additional efficacy & adverse events data from a phase III trial in Seasonal allergic rhinitis presented at the Annual Meeting of the American Academy of Allergy Asthma & Immunology (AAAAI-2013)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top